Effects of Artificial Sweeteners and Rare Sugars on the Gut Microbiome

Why this paper matters

If you formulate low-sugar products, the sweetener choice doesn’t end at taste. The gut microbiome is part of the equation now. A paper in Food Science and Biotechnology (DOI: 10.1007/s10068-024-01597-x) reviews how artificial sweeteners and rare sugars affect the gut microbiome. The strongest evidence points to rare sugars.

Background

The market for reduced-sugar foods keeps growing. But sugar does more than sweeten. It affects texture, browning, shelf life, and the gut bacteria. Replace it with something that tastes right but changes the microbiome, and you may create a different product. The paper looks at artificial sweeteners and rare sugars, including allulose and tagatose. These rare sugars have sweetness close to sucrose. They process easily. They are low-calorie. That makes them strong candidates for low-sugar product development.

What the paper did

The paper sits at the intersection of sweetener development and gut microbiology. It compares categories of sweeteners rather than focusing on one molecule. The authors included animal data, with Table 4 as a centerpiece. That table reports D-allulose fermentation in high-fat diet rats.

Key findings

The table below summarizes the gut-relevant effects reported.

Substance	Gut microbiome effect	Other reported effect
D-allulose	Fermented by gut microbiota into short-chain fatty acids (SCFAs)	Reduced body weight and lipid metabolism-related enzyme activity in high-fat diet rats
Isomaltulose	Increased Faecalibacterium and other probiotic genera; reduced pathogen abundance	Prebiotic activity

That table is useful. D-allulose is not just a low-calorie sweetener. It is metabolized by gut microbes. The resulting SCFAs are the kind of metabolites that gut researchers associate with metabolic benefits. In the animal model, the outcome was lower body weight and lower activity of enzymes linked to lipid metabolism.

Isomaltulose is different. It acts more like a prebiotic. In rats, it raised beneficial bacteria such as Faecalibacterium and cut pathogen numbers. That is a separate mechanism from sweetness. If you use isomaltulose, you may be adding a functional, fiber-like effect along with the sweet profile.

What it means for manufacturers

For formulators, the practical point is this: read beyond sweetness.

Allulose and tagatose give you sucrose-like sweetness and familiar processing behavior. They also carry a low-calorie profile. The added benefit is that allulose produces SCFAs through fermentation. That could matter for product claims around gut health, although you need human data before making any claim. The available evidence here is from rats.

Isomaltulose offers a different angle. If your target product is a bar, bakery item, or syrup where moderate sweetness and gut-friendly positioning matter, this ingredient deserves a closer look. The paper highlights its prebiotic activity directly.

The same logic applies to other rare sugars. Tagatose appears alongside allulose in the paper as a sucrose-like, low-calorie sweetener. The available evidence doesn’t spell out its microbiome effects, but its sensory and processing profile is clear.

FAQ

Q: Are allulose and tagatose good replacements for sugar? According to the paper, yes on the basics. Both have sweetness similar to sucrose, easy processability, and low calorie content. That combination is hard to find in most sugar alternatives.

Q: What does Table 4 in the paper show? Table 4 shows that D-allulose is fermented by gut microbiota to produce short-chain fatty acids. In high-fat diet rats, this was associated with reduced body weight and lower activity of lipid metabolism-related enzymes.

Q: Does isomaltulose act like a prebiotic? In the rat evidence reported here, isomaltulose increased Faecalibacterium and other probiotic genera while reducing pathogenic bacteria. The paper calls this prebiotic activity.

The gut microbiome is becoming a routine part of ingredient evaluation. This paper gives formulators a reason to include rare sugars in that evaluation. D-allulose already has the sensory and processing profile you want. The fermentation data add a metabolic angle. Isomaltulose offers a separate prebiotic pathway. Neither story is complete without human trials, but the direction is clear.